AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2025

Jun 3, 2025

30870_dirs_2025-06-03_428ad9a7-6cdf-4578-bd51-957838ebb35f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-06-02

Reporting Person: Lee Sung (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-02	Common Stock	F	4965	$31.21	Disposed	69477	Direct

Footnotes

F1: Transactions represent withholding of restricted stock units upon vesting of 13,874 restricted stock units. Reporting person received 8,909 net shares of common stock after the withholding transaction..